BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24296345)

  • 1. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
    Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
    Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
    George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
    Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
    Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
    Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morcellation of uterine smooth muscle tumor of uncertain malignant potential and endometrial stromal sarcoma: case series and recommendations for clinical practice.
    Mowers EL; Skinner B; McLean K; Reynolds RK
    J Minim Invasive Gynecol; 2015; 22(4):601-6. PubMed ID: 25596464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis.
    Bogani G; Cliby WA; Aletti GD
    Gynecol Oncol; 2015 Apr; 137(1):167-72. PubMed ID: 25462199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms.
    Seidman MA; Oduyebo T; Muto MG; Crum CP; Nucci MR; Quade BJ
    PLoS One; 2012; 7(11):e50058. PubMed ID: 23189178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results.
    Sugarbaker P; Ihemelandu C; Bijelic L
    Ann Surg Oncol; 2016 May; 23(5):1501-7. PubMed ID: 26545375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
    Raspagliesi F; Maltese G; Bogani G; FucĂ  G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
    Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morcellating uterine mesenchymal tumors: The pathologist's view.
    Pavlakis K; Messini I; Yiannou P; Gavresea T; Chrysanthakis D; Hilaris G; Panoskaltsis T
    J Obstet Gynaecol Res; 2017 Mar; 43(3):580-586. PubMed ID: 28120430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease.
    Lee JY; Kim HS; Nam EJ; Kim SW; Kim S; Kim YT
    BMC Cancer; 2016 Aug; 16(1):675. PubMed ID: 27553655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and survival in patients treated surgically for primary and recurrent uterine leiomyosarcoma: a single center experience.
    Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
    Anticancer Res; 2015 Apr; 35(4):2229-34. PubMed ID: 25862883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery.
    Oduyebo T; Hinchcliff E; Meserve EE; Seidman MA; Quade BJ; Rauh-Hain JA; George S; Nucci MR; del Carmen MG; Muto MG
    J Minim Invasive Gynecol; 2016 Jan; 23(1):34-9. PubMed ID: 26253281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult pre-malignant or malignant pathology at the time of uterine morcellation for benign disease.
    Von Bargen EC; Grimes CL; Mishra K; Wang R; Haviland MJ; Hacker MR; Carnevale JA; Estes AJ; Elkadry EA
    Int J Gynaecol Obstet; 2017 May; 137(2):123-128. PubMed ID: 28170091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental power morcellation of malignancy: a retrospective cohort study.
    Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
    Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center.
    Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM
    Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
    Mettler L; Abdusattarova K; Alkatout I
    Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.
    Casarin J; Ghezzi F; Lembo A; Artuso V; Schivardi G; Galati EF; Ambrosoli AL; Bogani G; Multinu F; Cromi A
    J Surg Oncol; 2024 Mar; 129(3):517-522. PubMed ID: 37974522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.